EKSO (Ekso Bionics Holdings) Days Payable : 64.52 (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Ekso Bionics Holdings Days Payable?

Ekso Bionics Holdings's average Accounts Payable for the three months ended in Dec. 2024 was $1.68 Mil. Ekso Bionics Holdings's Cost of Goods Sold for the three months ended in Dec. 2024 was $2.38 Mil. Hence, Ekso Bionics Holdings's Days Payable for the three months ended in Dec. 2024 was 64.52.

The historical rank and industry rank for Ekso Bionics Holdings's Days Payable or its related term are showing as below:

EKSO' s Days Payable Range Over the Past 10 Years
Min: 73.72 Med: 136.99 Max: 187
Current: 79.89

During the past 13 years, Ekso Bionics Holdings's highest Days Payable was 187.00. The lowest was 73.72. And the median was 136.99.

EKSO's Days Payable is ranked better than
55.74% of 793 companies
in the Medical Devices & Instruments industry
Industry Median: 69.21 vs EKSO: 79.89

Ekso Bionics Holdings's Days Payable declined from Dec. 2023 (80.07) to Dec. 2024 (64.52). It may suggest that Ekso Bionics Holdings accelerated paying its suppliers.

Ekso Bionics Holdings Days Payable Historical Data

The historical data trend for Ekso Bionics Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Days Payable Chart

Ekso Bionics Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

162.97

187.00

170.51

99.15

73.72

Ekso Bionics Holdings Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															80.07	94.11	78.92	93.46	64.52

Competitive Comparison of Ekso Bionics Holdings's Days Payable

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ekso Bionics Holdings's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Days Payable falls into.

Ekso Bionics Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ekso Bionics Holdings's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (1.847	+	1.552)	/	2 )	/	8.414	*	365
=	1.6995					/	8.414	*	365
=	73.72

Ekso Bionics Holdings's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (1.808	+	1.552)	/	2 )	/	2.376	*	365 / 4
=	1.68					/	2.376	*	365 / 4
=	64.52

Ekso Bionics Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ekso Bionics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (NAS:EKSO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

0IFR:UK 23E2:Germany

Address

101 Glacier Point, Suite A, San Rafael, CA, USA, 94901

Website

https://www.eksobionics.com

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Executives

Lathan Corinna	director	140 KENDRICK STREET, NEEDHAM MA 02494
Jerome Wong	officer: Interim CFO	C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Scott G. Davis	officer: President & COO	C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Steven Sherman	director
Jason C Jones	officer: VP of Product Development	EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
John Glenn	officer: Chief Financial Officer	7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577
William R Shaw	officer: See Remarks	1414 HARBOUR WAY SOUTH, SUITE 1201, C/O EKSO BIONICS HOLDINGS, INC., RICHMOND CA 94804
Rhonda A. Wallen	director	C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Mary Ann Cloyd	director	184 LIBERTY CORNER ROAD, SUITE 302, WARREN NJ 07059
Combest Development (hong Kong) Ltd	10 percent owner	ROOM 2210, CC WU BUILDING 302, HENNESSY ROAD, WAN CHAI, HONG KONG K3 999077
Jack Peurach	director, officer: Chief Executive Officer	1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Thomas A Schreck	director	10240 BUBB RD, CUPERTINO CA 95014
Puissance Capital Management (gp) Llc	10 percent owner	950 THIRD AVENUE, 25TH FLOOR, NEW YORK NY 10022
Theodore T Wang	director, 10 percent owner	C/O PUISSANCE CAPITAL MANAGEMENT LP, 950 THIRD AVENUE, 25TH FLOOR, NEW YORK NY 10022
Christian Babini	officer: VP of Sales, Americas	C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1, RICHMOND CA 94804